Pharmacokinetic and Injection Site Toleration of BIOD-238 and BIOD-250 Compared to Humalog® in Subjects With Type 1 Diabetes

Clinical trial NCT01811849 · COMPLETED

Trial details

NCT number: NCT01811849
Sponsor: Biodel
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2012-08-01
Primary completion: 2012-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.